| Category: ETFs |
| Launch Date: 05-07-2021 |
| Asset Class: |
| Benchmark: NIFTY Pharma TRI |
| Expense Ratio: 0.21% As on (30-06-2025) |
| Status: Open Ended Schemes for subscription |
| Minimum Investment: 1000.0 |
| Minimum Topup: 0.0 |
| Total Assets: 98.05 Cr As on (30-06-2025) |
| Turn over: 45 |
Scheme Performance (%) Data as on - 08-08-2025
| 1-Year Ret (%) | 3-Yrs Ret (%) | 5-Yrs Ret (%) | 10-Yrs Ret (%) | Since Launch Ret (%) | |
|---|---|---|---|---|---|
| Nippon India Nifty Pharma ETF | -2.75 | 18.91 | - | - | 10.81 |
| Nifty Pharma TRI | -0.91 | 19.7 | 14.7 | 6.27 | 14.33 |
| ETFs | 7.62 | 16.19 | 18.34 | 12.78 | 11.53 |
Yearly Performance (%)
Fund Managers
Jitendra Tolani
Investment Objective
The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
Growth of 10000 In SIP (Fund vs Benchmark)
Growth of 10000 In LUMPSUM (Fund vs Benchmark)
Rolling Returns
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Riskometer
| Key Statistics | Volatility | Sharpe Ratio | Alpha | Beta | Yield to Maturity | Average Maturity |
|---|---|---|---|---|---|---|
| Nippon India Nifty Pharma ETF | 12.37 | - | - | |||
| ETFs | - | - | - | - | - | - |
| Scheme Name | Launch Date |
1-Year Ret (%) |
2-Yrs Ret (%) |
3-Yrs Ret (%) |
5-Yrs Ret (%) |
10-Yrs Ret (%) |
|---|---|---|---|---|---|---|
| Nippon India Nifty Pharma ETF | 05-07-2021 | -2.75 | 17.75 | 18.91 | 0.0 | 0.0 |
| Mirae Asset Hang Seng TECH ETF | 06-12-2021 | 68.5 | 15.01 | 11.7 | 0.0 | 0.0 |
| Nippon India ETF Hang Seng BeES | 09-03-2010 | 55.87 | 20.15 | 14.1 | 5.75 | 5.75 |
| Mirae Asset NYSE FANG and ETF | 06-05-2021 | 55.33 | 41.85 | 43.56 | 0.0 | 0.0 |
| LIC MF Gold Exchange Traded Fund | 09-11-2011 | 46.38 | 29.64 | 23.99 | 12.12 | 14.3 |
| Quantum Gold Fund | 22-02-2008 | 45.49 | 29.25 | 23.48 | 11.63 | 13.87 |
| UTI Silver Exchange Traded Fund | 17-04-2023 | 45.13 | 25.12 | 0.0 | 0.0 | 0.0 |
| ICICI Prudential Gold ETF | 05-08-2010 | 45.04 | 29.24 | 23.47 | 11.74 | 13.83 |
| HDFC Gold ETF - Growth Option | 13-08-2010 | 45.03 | 29.11 | 23.38 | 11.66 | 13.94 |
| Invesco India Gold Exchange Traded Fund | 12-03-2010 | 44.99 | 29.35 | 23.61 | 11.83 | 14.06 |
Asset Allocation (%)
Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing. Past performance is not indicative of future returns. Please consider your specific investment requirements before choosing a fund, or designing a portfolio that suits your needs.
Mf Online Inc (with ARN code 160300) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
